Related Experiment Video
Updated: Jul 20, 2026

Repeated Transcranial Magnetic Stimulation Combined with Action Observation Training in Children with Spastic Cerebral Palsy
Published on: August 9, 2024
Head growth in infants with infantile spasms may be temporarily reduced
Zvonka Rener-Primec1, Jana Lozar-Krivec, Uros Krivec
1Department of Child, Adolescent and Developmental Neurology, University Children's Hospital, Ljubljana, Slovenia. zvonka.rener@mf.uni-lj.si
Insights
Infants with infantile spasms may experience temporary head growth reduction. Head circumference below the tenth percentile predicts later mental retardation in these children.
Area of Science:
- Pediatric Neurology
- Developmental Neuroscience
Background:
- Epileptic activity, a feature of epileptic encephalopathies, can impede brain development.
- Infantile spasms (IS) represent a specific epileptic syndrome affecting infants.
- The impact of IS on head growth rates has not been previously investigated.
Purpose of the Study:
- To investigate the rate of head growth in infants diagnosed with infantile spasms.
- To determine if head circumference measurements can predict mental outcomes in infants with IS.
Main Methods:
- A retrospective study involving 38 infants with infantile spasms.
- Analysis of head circumference measurements during the period of spasms.
- Assessment of mental outcomes at follow-up.
Main Results:
- While mean head circumference was not significantly smaller than normal, a higher proportion (27%) of infants with IS had head circumference below the tenth percentile.
- Head circumference below the tenth percentile at 4-5 months post-IS onset significantly correlated with later mental retardation (P = 0.004).
- No correlation was found between specific IS treatments and head circumference outcomes.
Conclusions:
- Transiently diminished head growth in infants with IS temporally aligns with spasm onset and can recover during remission.
- Epileptic activity during sensitive developmental periods may negatively influence brain growth.
- Head circumference serves as a reliable predictor of mental outcomes in children with infantile spasms.
Abstract:
Epileptic activity, as a component of epileptic encephalopathies, can interfere with brain growth and development. Infantile spasms as a syndrome represent such epileptic activity during the period of spasms and hypsarrhythmia. The rate of head growth in infants with infantile spasms during the period of spasms has not been studied previously. A retrospective study of head growth in 38 infants with infantile spasms and no other cause of abnormal head growth is presented. Mental outcome was assessed at follow-up. The mean head circumference of infants with infantile spasms was not significantly smaller than in the normal population, but the proportion of head circumference below the tenth percentile in the infantile spasms group was higher (27%). Head circumference below the tenth percentile in the fourth and fifth month after the onset of infantile spasms was significantly associated with later mental retardation (P = 0.004). There was no correlation with specific treatment of infantile spasms. Transiently diminished head growth in infants with infantile spasms coincides temporally with the onset of infantile spasms and "catches up" during remission of infantile spasms in favorable cases. This pattern can reflect the negative influence of epileptic activity on brain growth during the sensitive period. Head circumference can provide a reliable predictive value of mental outcome in children with infantile spasms.
Related Concept Videos
Classification of Skeletal Muscle Relaxants
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Skeletal Muscle Relaxants: Therapeutic Uses
Centrally Acting Muscle Relaxants: Therapeutic Uses
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Spasmolytic Agents: Chemical Classification
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also promote...
Tetanus

